Gene · 9184
Papers1,385
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,385
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular mechanism of Mad2 conformational conversion promoted by the Mad2-interaction motif of Cdc20. | Protein Sci | 2025 | 40143766 | PubTator, text mining | PubMed |
| Comprehensive analysis of intervention and control studies for the computational identification of dengue biomarker genes. | PLoS Negl Trop Dis | 2025 | 40100920 | PubTator, text mining | PubMed |
| OBSCN undergoes extensive alternative splicing during human cardiac and skeletal muscle development. | Skelet Muscle | 2025 | 40025502 | PubTator, text mining | PubMed |
| mir-188-5p emerges as an oncomir to promote chronic myeloid leukemia via upregulation of BUB3 and SUMO2. | Mol Biol Rep | 2025 | 40019654 | PubTator, text mining | PubMed |
| FRET-FLIM for the Study of Protein-Protein Interactions Underpinning Mitosis Checkpoints. | Methods Mol Biol | 2025 | 39614049 | PubTator, text mining | PubMed |
| Production of SAC Proteins in a Baculovirus-Based Heterologous Gene Expression System. | Methods Mol Biol | 2025 | 39614045 | PubTator, text mining | PubMed |
| A whole-genome CRISPR screen identifies the spindle accessory checkpoint as a locus of nab-paclitaxel resistance in a pancreatic cancer cell line. | Sci Rep | 2024 | 38987356 | PubTator, text mining | PubMed |
| Genetic Variations Affect Chemotherapy Outcomes: A Role of the Spindle-assembly Checkpoint. | Indian J Public Health | 2024 | 38953826 | PubTator, text mining | PubMed |
| YY2/BUB3 Axis promotes SAC Hyperactivation and Inhibits Colorectal Cancer Progression via Regulating Chromosomal Instability. | Adv Sci (Weinh) | 2024 | 38682484 | PubTator, text mining | PubMed |
| A case report of a family with developmental arrest of human prokaryotic stage zygote. | Front Cell Dev Biol | 2024 | 38606321 | PubTator, text mining | PubMed |
| Retraction Note: The long noncoding RNA CRYBG3 induces aneuploidy by interfering with spindle assembly checkpoint via direct binding with Bub3. | Oncogene | 2024 | 38443684 | PubTator, text mining | PubMed |
| Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasms. | Sci Rep | 2024 | 38308077 | PubTator, text mining | PubMed |
| m6A demethylase ALKBH5 maintains stemness of intrahepatic cholangiocarcinoma by sustaining BUB1B expression and cell proliferation. | Transl Oncol | 2024 | 38242006 | PubTator, text mining | PubMed |
| Tumor microenvironment deconvolution identifies cell-type-independent aberrant DNA methylation and gene expression in prostate cancer. | Clin Epigenetics | 2024 | 38173042 | PubTator, text mining | PubMed |
| Age-dependent loss of cohesion protection in human oocytes. | Curr Biol | 2024 | 38134935 | PubTator, text mining | PubMed |
| Cyclin A/Cdk1 promotes chromosome alignment and timely mitotic progression. | bioRxiv | 2023 | 38187612 | PubTator, text mining | PubMed |
| DNA Conserved in Diverse Animals Since the Precambrian Controls Genes for Embryonic Development. | Mol Biol Evol | 2023 | 38085182 | PubTator, text mining | PubMed |
| Potential therapies targeting nuclear metabolic regulation in cancer. | MedComm (2020) | 2023 | 38034101 | PubTator, text mining | PubMed |
| Role of Kinetochore Scaffold 1 (KNL1) in Tumorigenesis and Tumor Immune Microenvironment in Pan-Cancer: Bioinformatics Analyses and Validation of Expression. | Int J Gen Med | 2023 | 37928953 | PubTator, text mining | PubMed |
| Unraveling the role of disulfidptosis-related LncRNAs in colon cancer: a prognostic indicator for immunotherapy response, chemotherapy sensitivity, and insights into cell death mechanisms. | Front Mol Biosci | 2023 | 37916187 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9184/papers?page=2